Division of Strategic Planning and Evaluation FY2018 List of Projects - Research Program on Emerging and Re-emerging Infectious Diseases

First Year	Final Year	Principal Investigator	Affiliation		Project Title
FY2016	FY2018	Masayuki Shimojima	National Institute of Infectious Dieseases	Chief	Research on diagnosis, treatment, and preventive measures of emerging and re-emerging infectious diseases including viral hemorrhagic fevers
FY2016	FY2018	Masayuki Saijo	National Institute of Infectious Dieseases	Director	Research on the diagnostic, therapeutic, and preventive measures' development for and on the infection risk factors' analyses on severe fever with thrombocytopenia syndrome
FY2016	FY2018	Noriko Nakajima	National Institute of Infectious Dieseases	Chief	International collaborative research on diagnosis and treatment based on clinicopathological study of highly pathogenic avian influenza virus infection
FY2016	FY2018	Hiroyuki Shimizu	National Institute of Infectious Dieseases	Chief	Studies toward the development of surveillance, diagnosis, prevention, and therapy of emerging and re-emerging enterovirus infections
FY2016	FY2018	Toshiki Tamura	National Institute of Infectious Dieseases	Laboratory Head	Studies on the prophylaxis for active or latent tuberculosis and the development of new drugs for the treatment of multi-drug resistant tuberculosis
FY2016	FY2018	Masaji Okada	National Hospital Organization Kinki-Chuo Chest Medical Center	Visiting Senior Scientist	A Novel Therapeutic Vaccine against Multi-Drug Resistant Tuberculosis in the Preclinical Study and Clinical Trial
FY2016	FY2018	Yasuhiro Yasutomi	National Institutes of Biomedical Innovation, Health and Nutrition	Director	Development of novel tuberculosis vaccine inducing mucosal immune responses
FY2016	FY2018	Shigeru Kohno	Nagasaki University	President	Translational research on deep-seated and superficial mycoses from elucidation of host-fungal interaction to clinical outcome improvement
FY2016	FY2018	Haruhiko Maruyama	University of Miyazaki	Professor	Development of optimal medical care network for the diagnosis and treatment of tropical and parasitic diseases in Japan
FY2016	FY2018	Kisaburo Nagamune	National Institute of Infectious Dieseases	Chief	Molecular epidemiological study of Toxoplasma gondii in Japan and development of novel diagnostic method of toxoplasmosis
FY2016	FY2018	Shigeyuki Itamura	National Institute of Infectious Diseases	Laboratory Chief	Studies on the development of new quality control tests for influenza vaccines and establishment of measurement of vaccine efficacy
FY2016	FY2018	Hideki Hasegawa	National Institute of Infectious Diseases	Director	Study on the development of mucosal immunity inducible influenza vaccine
FY2016	FY2018	Yoshio Mori	National Institute of Infectious Diseases	Chief	Research on laboratory diagnosis and laboratory network supporting achievement and maintenance of measles and rubella elimination
FY2016	FY2018	Minoru Kidokoro	National Institute of Infectious Diseases	Laboratory Chief	Studies on the development of novel mumps vaccines with high efficacy, high safety, and usability
FY2016	FY2018	Shigeru Suga	National Hospital Organization Mie National Hospital	Vice Director	Basic and clinical research on vaccine effectiveness, safety in widely vaccinated population and immunization methods
FY2016	FY2018	Toru Hifumi	St. Luke's International Hospital	Assistant Chief of Staff	Quality control and clinical study of antitoxins
FY2016	FY2018	Shigeru Morikawa	National Institute of Infectious Diseases	Director	Study on strengthening of laboratory test, diagnosis, prevention and surveillance and pre-correspondence contributing to control of zoonoses
FY2016	FY2018	Koji Ishii	National Institute of Infectious Diseases	Section Chief	Development of new replication system for pathogens without established culture system and its application for diagnosis, treatment and prevention
FY2016	FY2018	Makoto Kuroda	National Institute of Infectious Diseases	Director	Studies for infectious disease control based on a rapid and comprehensive pathogen genome analysis using next-generation sequencing
FY2016	FY2018	Masato Suzuki	National Institute of Infectious Diseases	Senior Researcher	Discovery and development of novel antimicrobials against extensively drug-resistant gram-negative bacteria
FY2016	FY2018	Kunihiko Nishino	Osaka University	Professor	Research on the Development of Inhibitors of Bacterial Multidrug Efflux Pumps
FY2016	FY2018	Yoshichika Arakawa	Nagoya University Graduate School of Medicine	Professor	Development of new carbapenemase inhibitors on the basis of approved medicines showing inhibitory effect against carbapenemases
FY2016	FY2018	Jun Kunisawa	National Institutes of Biomedical Innovation, Health and Nutrition	Project leader	Development of polyvalence vaccine and diagnosis for enteric pathogens using antibody library system
FY2016	FY2018	Ryoma Nakao	National Institute of Infectious Diseases	Senior Research Scientist	Intranasal Vaccine Using Bacterial Membrane Vesicles –For Establishment of the Research Platform and Development–
FY2016	FY2018	Naoki Okada	Osaka University	Professor	Promotion of practical application of “patch vaccine formulation” utilizing microneedle technology
FY2016	FY2018	Misako Yoneda	The University of Tokyo	Associate Professor	Development of a drug for Nipah virus infection
FY2016	FY2018	Masao Matsuoka	Kumamoto University	Professor	Development of new diagnostic, prophylactic, and therapeutic methods according to the characters of HTLV-1-infected cells
FY2017	FY2019	Jiro Yasuda	Nagasaki University	Professor	Research and development of therapeutics, diagnostics and preventive measures for containment of viral hemorrhagic fevers
FY2017	FY2019	Yoshihiro Kawaoka	The University of Tokyo	Professor	Development of next generation Ebola virus vaccines
FY2017	FY2019	Tsutomu Kageyama	National Institute of Infectious Diseases	Chief	Development of diagnostic function for emerging pandemic influenza viruses and respiratory viruses
FY2017	FY2019	Shinji Watanabe	National Institute of Infectious Diseases	Chief	Prediction models of novel antigenic variants of seasonal influenza viruses and application for selection of viruses for influenza vaccine
FY2017	FY2019	Makoto Takeda	National Institute of Infectious Diseases	Director	Research for development of laboratory systems for national and global surveillance for respiratory syncytial virus infection
FY2017	FY2019	Hirokazu Kimura	Gunma Paz University	Professor	Studies on molecular epidemiology and epidemic prediction of the gastroenteric virus infections
FY2017	FY2019	Yuichi Someya	National Institute of Infectious Diseases	Senior Researcher	Studies on pathogenesis of diarrheal viruses and development of anti-viral drugs and vaccines
FY2017	FY2019	Chang-Kweng Lim	National Institute of Infectious Diseases	Chief	Establishing surveillance system for the risk of outbreaks of emerging and re-emerging insect-borne diseases in Japan and developing comprehensive insect-borne virus control system
FY2017	FY2019	Yoshiharu Matsuura	Osaka University	Director, Professor	Characterization of host factors involved in the propagation and pathogenesis of insect-borne viruses and development of preventive and therapeutic measures targeting these host factors
FY2017	FY2019	Isao Hamaguchi	National Institute of Infectious Diseases	Director	Epidemiological study regarding HTLV-1 infection and comprehensive effective strategy for its infection inhibition
FY2017	FY2019	Tetsuro Matano	National Institute of Infectious Diseases	Director	Development of a vaccine against HTLV-1 prevalence and disease progression
FY2017	FY2019	Kaoru Uchimaru	The University of Tokyo	Professor	Investigation of Putative Common Mechanism of ATL/HAM Development and Clinical Entity of Chronic Active HTLV-1 Infection
FY2017	FY2019	Akifumi Takaori-Kondo	Kyoto University	Professor	Study on the impaired DNA repair induced by HTLV-1 infection and its role in leukemogenesis and development of a novel therapeutic strategy
FY2017	FY2019	Seiya Kato	The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association	Director	Multi-dimensional research on strengthening tuberculosis control program in Japan to accelerate tuberculosis low incidence
FY2017	FY2019	Toshio Hattori	KIBI International University	Professor	Comprehensive Strategies against Multidrug-Resistant Tuberculosis utilizing Overseas Networks
FY2017	FY2019	Manabu Ato	National Institute of Infectious Diseases	Director	Establishment of epidemiological investigation, diagnostic tools, and therapeutics of non-tuberculous mycobacteria
FY2017	FY2019	Tadayoshi Ikebe	National Institute of Infectious Diseases	Senior researcher	Research on the pathogenesis-related factors of streptococcal toxic shock syndrome and research towards development of novel therapeutic methods
FY2017	FY2019	Yoshitsugu Miyazaki	National Institute of Infectious Diseases	Director	Investigation of breakthrouh innovation for prevalence, novel diagnosis and treatment to overcomethe invasive fungal infection by yeasts
FY2017	FY2019	Tomoyoshi Nozaki	The University of Tokyo	Professor	Integrated Project on Development of New Diagnostics, Surveillance System, Pathogen Genome Database, and Elucidation of Mechanisms of Drug Resistance, Pathogenesis and Parasitism
FY2017	FY2019	Masahiro Yamamoto	Osaka University	Professor	Research and Development for Comprehensive Measures against Toxoplasmosis
FY2017	FY2019	Makoto Kuroda	National Institute of Infectious Diseases	Director	Genomics application for controlling antimicrobial resistant-bacteria using an integrated database of pathogen genomics and epidemiology (GenEpid-J)
FY2017	FY2019	Makoto Ohnishi	National Institute of Infectious Diseases	Deputy Director-General	Construction of laboratory network among the research institutions for infectious diseases in Asian countries
FY2017	FY2019	Hiroshi Nishiura	Hokkaido University	Professor	Project organization and implementation of epidemiological modeling studies of infectious diseases for assisting healthcare assosciated policy making
FY2017	FY2019	Yoshimasa Takahashi	National Institute of Infectious Diseases	Laboratory chief	Rational design of novel vaccines with improved efficacy and safety
FY2017	FY2019	Katsunori Yanagihara	Nagasaki University	Professor	Research and development of diagnostic methods and therapies for antimicrobial resistant bacteria
FY2017	FY2019	Tetsuro Suzuki	Hamamatsu University School of Medicine	Professor	Understanding of dynamics of Zika virus infection and its immune responses in the common marmoset model
FY2017	FY2019	Yoshitoshi Ogura	Kyushu University	Associate professor	Development of new therapeutic strategy for enterohemorrhagic Escherichia coli infection using Shiga toxin-neutralizing plastic antibody
FY2017	FY2019	Takeshi Noda	Kyoto University	Professor	Antiviral drug development for Ebola virus disease and Lassa fever
FY2018	FY2020	Yoshihiro Kawaoka	The University of Tokyo	Professor	Study on risk assessment and vaccine development for highly pathogenic avian H7N9 influenza viruses emerged in China
FY2018	FY2020	Eri Nobusawa	National Institute of Infectious Diseases	Lab chief	Study of the cell-based influenza vaccine
FY2018	FY2020	Tsuneo Morishima	Aichi Medical University	Visitng Professor	Research on the diagnosis and treatment of severe respiratory infections caused by viruses
FY2018	FY2020	Takuo Mizukami	National Institute of Infectious Diseases	Section Chief	Development of hyper-immune-Globulin against HTLV-1 infection and disease progression
FY2018	FY2020	Yuetsu Tanaka	University of the Ryukyus	Professor	Generation of recombinant human immunoglobulin drugs and verification using a non-human primatemodel for development of passive immunization prophylaxis against mother to child vertical infection with HTLV-1
FY2018	FY2020	Keigo Shibayama	National Institute of Infectious Diseases	Director	Research and development of new technologies for comprehensive infection control of emerging and re-emerging Antimicrobial Resistance
FY2018	FY2020	Makoto Ohnishi	National Institute of Infectious Diseases	Deputy Director-General	Research for control of antimicrobial resistant Neisseria gonorrhoeae infection
FY2018	FY2020	Satoshi Mitarai	The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association	Professor/Head	Technology development for tuberculosis infection control with OMICS information
FY2018	FY2020	Yoshihiko Hoshino	National Institute of Infectious Diseases	Division Chair	Studies toward the development of prophylaxis, diagnosis and treatment of leprosy and other mycobacterial skin diseases
FY2018	FY2020	Sunao iyoda	National Institute of Infectious Diseases	Chief	Research for the establishment of surveillance method and virulence evaluation system of deiarrheagenic enterobacteria
FY2018	FY2020	Kazunori Oishi	National Institute of Infectious Diseases	Director	Researches on surveillance for vaccine-preventable diseases and evaluation of vaccine effectiveness
FY2018	FY2020	Kyoko Sawabe	National Institute of Infectious Diseases	Director	Studies of arthropods involved in vector-borne diseases
FY2018	FY2020	Shuji Ando	National Institute of Infectious Diseases	Chief	Research for syntetic strategy of tick-borne bacterial diseases
FY2018	FY2020	Ken Maeda	Yamaguchi University	Professor	Establishment of system for diagnosis and information sharing of zoonosis transmitted by companion animals
FY2018	FY2020	Shuetsu Fukushi	National Institute of Infectious Diseases	Senior research scientist	Research on the improvement of the bio-risk management systems of highly pathogenic agents
FY2018	FY2020	Ryoichi Saito	Tokyo Medical and Dental University	Associate professor	Research and development of effective testing and surveillance strategies for meningococcal disease in mass gatherings
FY2018	FY2020	Masayuki Saijo	National Institute of Infectious Diseases	Director	Research on the therapeutic and preventive measures against highly pathogenic virus infections: development of vaccines to and animal models of highly pathogenic virus infections
FY2018	FY2020	Ichiro Nakagawa	Kyoto University	Professor	Construction of optimized antibody production platform for development of new diagnostic and therapeutic drugs against bacterial infections
FY2018	FY2020	Yasuo Yoshioka	Osaka University	Specially-Appointed Associate Professor	Creation of dendritic cell-targeting peptides as vaccine delivery vehicle for the development of vaccine against infectious diseases
FY2018	FY2020	Yoshihiko Hoshino	National Institute of Infectious Diseases	Division Chair	The development of novel treatment strategy regarding the functional comprehension of inducible and inhibitory innate receptor under the latency and re-activation of mycobacterial infection
FY2018	FY2020	Atsushi Kawaguchi	University of Tsukuba	Assistant Professor	Molecular basis for mammalian adaptation of emerging influenza virus
FY2018	FY2020	Ryohei Hirose	Kyoto Prefectural University of Medicine	Assistant Professor	Analysis of the onset mechanism and clinicopathological characteristics of seasonal influenza-related enteritis
FY2018	FY2020	Yoshiki Fujii	National Institute of Infectious Diseases	Senior Researcher	Molecular epidemiological study of rotaviruses based on full genome analysis after vaccine introduction
FY2018	FY2020	Shogo Ozaki	Kyushu University	Associate Professor	A novel approach to identify selective inhibitors for microbial biofilms

Last updated 05/22/18